Trends in mortality risk of patients with congenital heart disease during the COVID-19 pandemic
Yanxu Yang(Yangzhou University), Lazaros Kochilas(Emory Healthcare), Yijian Huang, J’Neka S. Claxton(Emory University), Kristina W Kuo(Emory University), Matthew E. Oster(Children's Healthcare of Atlanta), Jessica Knight(Emory University)
Cited by 3
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
|JAMA|2022|670
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
|JAMA Network Open|2021|404
D-Transposition of the Great Arteries
|Journal of the American College of Cardiology|2014|289